All In Biotech

Free tool

FAERS Monitor: Genvoya

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207561 or its brand name (Genvoya, Cobicistat, Elvitegravir, Emtricitabine, Tenofovir Alafenamide Fumarate). Reports on generic versions are filed under their own applications.

Reports

10,045

Serious

7,813

78% of reports

Hospitalization

1,145

Death reported

199

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bone density decreased4,545
  • chronic kidney disease2,641
  • bone loss2,432
  • osteonecrosis2,397
  • tooth loss2,280
  • multiple fractures2,144
  • renal failure2,119
  • osteoporosis1,952
  • renal injury1,931
  • pain1,867
  • emotional distress1,812
  • skeletal injury1,662
  • anxiety1,644
  • anhedonia1,570
  • osteopenia1,212

Reports by year received

View as table
YearReports
20153
2016242
2017524
2018812
20191,136
20204,082
20211,336
2022783
2023358
2024378
2025302
202689

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,114 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone lossSignal2,432403.9388.5819,610
skeletal injurySignal1,662400.7381.6556,160
bone density decreasedSignal4,545355.0346.41,373,741
multiple fracturesSignal2,144314.1301.5582,089
tooth lossSignal2,280258.5248.7520,953
osteopeniaSignal1,212181.7171.9200,349
osteonecrosisSignal2,397164.7158.8362,081
renal injurySignal1,931145.5139.5259,281
anhedoniaSignal1,570133.0126.8193,471
osteoporosisSignal1,952104.3100.1190,455
chronic kidney diseaseSignal2,64175.472.9187,661
renal failureSignal2,11933.932.767,047
emotional distressSignal1,81231.830.553,523
anxietySignal1,64412.211.616,959
painSignal1,8676.46.18,694

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.